Gagandeep Kang

Prof.
Gagandeep Kang
Born (1962-03-11) March 11, 1962
Nationality Indian
Occupation Medical scientist/Academic
Academic background
Education MBBS, MD, PhD, FRCPath
Alma mater Christian Medical College, Vellore
Academic work
Discipline Microbiology
Sub-discipline Vaccinologist, Virologist, Public Health
Institutions Christian Medical College, Vellore
Main interests Rotavirus, diarrheal diseases, vaccines, public health
Website http://cmcwtrl.in/

Gagandeep Kang (Cherry) is a clinician scientist and Professor in the Department of Gastrointestinal Sciences at Christian Medical College, Vellore, South India.[1] She is a leading researcher on diarrheal diseases with a major research focus on rotaviral infections in children, and the testing of rotaviral vaccines. She also works on other enteric infections and their consequences when children are infected in early life, sanitation and water safety.

She is also the executive director of Translational Health Science and Technology institute (THSTI),Faridabad and also the current chair of WHO Southeast-Asia regions immunization Technical Advisory Group.[1][1]

Education

Gagandeep Kang completed her MBBS in 1986 and her MD in Microbiology in 1991 from Christian Medical College, Vellore and obtained her PhD in 1997.[1] She obtained her membership of the Royal College of Pathologists and carried out post doctoral research with Dr Mary Estes at Baylor College of Medicine, Houston before returning to Vellore. Her father was an engineer and worker in the railways.[1]

Contributions to science

Gagandeep Kang is a medical scientist who has worked on diarrhoea diseases and public health in India since the early 1990s. She is a key contributor to rotavirus epidemiology and vaccinology in India. Focusing on vaccines, enteric infections and nutrition in young children in disadvantaged communities, she has combined field epidemiology with intensive laboratory investigations to inform both the science of infectious diseases and policy in India. Her comprehensive research on rotavirus has demonstrated the high burden of rotavirus disease across India and the genetic diversity of viruses.[2] In particular, she has conducted the largest single birth cohort study on rotaviral infections in the world demonstrating that protection after natural infection is lower in India than in developed countries, which has important implications for control of disease by vaccination.[3][4]

She has published over 250 scientific papers and is on editorial boards for several journals, including PLoS Neglected Tropical Diseases, Current Opinion in Infectious Diseases and f Tropical Medicine and International Health. She is on many review committees for national and international research funding agencies, and has served on several advisory committees mainly related to vaccines, including India's National Technical Advisory Group on Immunisation, the WHO's Global Advisory Committee on Vaccine Safety and the Immunisation and Vaccine Implementation Research Advisory Committee. She chairs the WHO SEAR's Regional Immunisation Technical Advisory Group (2015-current).

Awards and recognition

  1. 2006 Woman Bioscientist of the Year (link)
  2. 2008 Fellow, Royal College of Pathologists, London
  3. 2009 Abbott Oration Award, Indian Society for Gastroenterology
  4. 2010 Fellow, American Academy of Microbiology
  5. 2011 Fellow, Indian Academy of Sciences
  6. 2011 Dr. Y.S. Narayana Rao Oration Award Indian Council of Medical Research
  7. 2013 Fellow, National Academy of Sciences
  8. 2014 Ranbaxy Research Award 2013 for Medical Research (link)
  9. 2015 Dr. S.C. Parija Oration Award, Indian Academy of Tropical Parasitology
  10. 2016 Fellow, Indian National Science Academy
  11. 2016 Infosys Prize in Life Sciences[5]

She is the ninth woman to be awarded the Infosys Prize in 2016 for her contributions to understanding the natural history of rotavirus and other infectious diseases.[1][1] She is currently on the advisory committee of Human Enteric Microbiota Advisory Group, Bill and Melina Gates Foundation (2016 present). She has served as an investigator on national and intentionally funded diarrheal disease research grants.[1][1]

References

  1. 1 2 3 4 5 6 7 8 9 "Infosys Prize - Laureates 2016 - Prof. Gagandeep Kang". www.infosys-science-foundation.com. Retrieved 2018-01-20.
  2. Kang, Gagandeep; Desai, Rishi; Arora, Rashmi; Chitamabar, Shobha; Naik, Trilok Nath; Krishnan, Triveni; Deshpande, Jagdish; Gupte, Mohan D.; s. Venkatasubramaniam; Gentsch, Jon R.; Parashar, Umesh D. (2013). "Diversity of circulating rotavirus strains in children hospitalized with diarrhea in India, 2005–2009". Vaccine. 31 (27): 2879–83. doi:10.1016/j.vaccine.2013.04.030. PMID 23624096.
  3. Gladstone, Beryl P.; Ramani, Sasirekha; Mukhopadhya, Indrani; Muliyil, Jayaprakash; Sarkar, Rajiv; Rehman, Andrea M.; Jaffar, Shabbar; Gomara, Miren Iturriza; Gray, James J.; Brown, David W.G.; Desselberger, Ulrich; Crawford, Sue E.; John, Jacob; Babji, Sudhir; Estes, Mary K.; Kang, Gagandeep (2011). "Protective Effect of Natural Rotavirus Infection in an Indian Birth Cohort". New England Journal of Medicine. 365 (4): 337–46. doi:10.1056/NEJMoa1006261. PMC 3596855. PMID 21793745.
  4. Bhandari, Nita; Rongsen-Chandola, Temsunaro; Bavdekar, Ashish; John, Jacob; Antony, Kalpana; Taneja, Sunita; Goyal, Nidhi; Kawade, Anand; Kang, Gagandeep; Rathore, Sudeep Singh; Juvekar, Sanjay; Muliyil, Jayaprakash; Arya, Alok; Shaikh, Hanif; Abraham, Vinod; Vrati, Sudhanshu; Proschan, Michael; Kohberger, Robert; Thiry, Georges; Glass, Roger; Greenberg, Harry B.; Curlin, George; Mohan, Krishna; Harshavardhan, G.V.J.A.; Prasad, Sai; Rao, T.S.; Boslego, John; Bhan, Maharaj Kishan; India Rotavirus Vaccine, Group (2014). "Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life". Vaccine. 32: A110–6. doi:10.1016/j.vaccine.2014.04.079. PMID 25091663.
  5. PTI (2016-11-18). "Winners of Infosys Prize 2016 announced". livemint.com/. Retrieved 2017-04-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.